These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8183439

  • 1. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus.
    Mundey MK, Fletcher A, Marsden CA.
    Neuropharmacology; 1994 Jan; 33(1):61-6. PubMed ID: 8183439
    [Abstract] [Full Text] [Related]

  • 2. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.
    Mundey MK, Fletcher A, Marsden CA.
    Br J Pharmacol; 1996 Feb; 117(4):750-6. PubMed ID: 8646424
    [Abstract] [Full Text] [Related]

  • 3. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L, Haj-Dahmane S, Hamon M.
    Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017
    [Abstract] [Full Text] [Related]

  • 4. Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats.
    Fornal CA, Marrosu F, Metzler CW, Tada K, Jacobs BL.
    J Pharmacol Exp Ther; 1994 Sep 02; 270(3):1359-66. PubMed ID: 7932190
    [Abstract] [Full Text] [Related]

  • 5. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
    Arborelius L, Nomikos GG, Grillner P, Hertel P, Höök BB, Hacksell U, Svensson TH.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug 02; 352(2):157-65. PubMed ID: 7477438
    [Abstract] [Full Text] [Related]

  • 6. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B.
    Eur J Pharmacol; 1997 May 01; 325(2-3):145-53. PubMed ID: 9163561
    [Abstract] [Full Text] [Related]

  • 7. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
    Evrard A, Laporte AM, Chastanet M, Hen R, Hamon M, Adrien J.
    Eur J Neurosci; 1999 Nov 01; 11(11):3823-31. PubMed ID: 10583471
    [Abstract] [Full Text] [Related]

  • 8. WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.
    Fletcher A, Bill DJ, Bill SJ, Cliffe IA, Dover GM, Forster EA, Haskins JT, Jones D, Mansell HL, Reilly Y.
    Eur J Pharmacol; 1993 Jun 24; 237(2-3):283-91. PubMed ID: 8365456
    [Abstract] [Full Text] [Related]

  • 9. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.
    Starkey SJ, Skingle M.
    Neuropharmacology; 1994 Jun 24; 33(3-4):393-402. PubMed ID: 7984277
    [Abstract] [Full Text] [Related]

  • 10. Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function.
    Garratt JC, Crespi F, Mason R, Marsden CA.
    Eur J Pharmacol; 1991 Jan 25; 193(1):87-93. PubMed ID: 1710990
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
    Gronier B.
    Neuroscience; 2008 Oct 28; 156(4):995-1004. PubMed ID: 18801415
    [Abstract] [Full Text] [Related]

  • 13. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A.
    Eur J Pharmacol; 1995 Jul 25; 281(1):81-8. PubMed ID: 8566121
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP, Jackson DM, Wallsten C, Waszczak BL.
    J Pharmacol Exp Ther; 1999 Feb 25; 288(2):820-6. PubMed ID: 9918594
    [Abstract] [Full Text] [Related]

  • 15. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
    Fornal CA, Martin FJ, Metzler CW, Jacobs BL.
    J Pharmacol Exp Ther; 1999 Oct 25; 291(1):229-38. PubMed ID: 10490909
    [Abstract] [Full Text] [Related]

  • 16. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    Fornal CA, Litto WJ, Metzler CW, Marrosu F, Tada K, Jacobs BL.
    J Pharmacol Exp Ther; 1994 Sep 25; 270(3):1345-58. PubMed ID: 7932189
    [Abstract] [Full Text] [Related]

  • 17. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG, Beneytez ME, Delgado M, Manzanares J, López-Rodríguez ML, Benhamu B, Morcillo MJ, Pozo MA, Rubia FJ, Fuentes JA.
    Pharmacology; 2001 May 25; 62(4):234-42. PubMed ID: 11360001
    [Abstract] [Full Text] [Related]

  • 18. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
    Fornal CA, Metzler CW, Gallegos RA, Veasey SC, McCreary AC, Jacobs BL.
    J Pharmacol Exp Ther; 1996 Aug 25; 278(2):752-62. PubMed ID: 8768728
    [Abstract] [Full Text] [Related]

  • 19. The 5-HT1A receptor antagonist (S)-UH-301 blocks the qR)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat.
    Arborelius L, Höök BB, Hacksell U, Svensson TH.
    J Neural Transm Gen Sect; 1994 Aug 25; 96(3):179-86. PubMed ID: 7826569
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.
    Sprouse JS, Reynolds LS, Braselton JP, Rollema H, Zorn SH.
    Neuropsychopharmacology; 1999 Nov 25; 21(5):622-31. PubMed ID: 10516958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.